DDInter517 DDInter1180
Dexbrompheniramine maleate is an antihistamine agent that is used for the treatment of allergic conditions, such as hay fever or urticaria.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Dexbrompheniramine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Carbinoxamine
Dexbrompheniramine {u} (Compound) resembles {v} (Compound) Bepotastine
Dexbrompheniramine {u} (Compound) resembles {v} (Compound) Captodiame
Dexbrompheniramine {u} (Compound) binds {v} (Gene) KCNH2
Dexbrompheniramine {u} (Compound) downregulates {v} (Gene) IER3
Dexbrompheniramine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Hyaluronidase
Dexbrompheniramine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Valproic acid
Dexbrompheniramine {u} may lead to a major life threatening interaction when taken with {v} Potassium chloride
Dexbrompheniramine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Doxylamine
Dexbrompheniramine may cause a moderate interaction that could exacerbate diseases when taken with Carbinoxamine
Dexbrompheniramine (Compound) resembles Bepotastine (Compound)
Dexbrompheniramine (Compound) resembles Captodiame (Compound)
Dexbrompheniramine (Compound) binds KCNH2 (Gene)
Dexbrompheniramine (Compound) downregulates IER3 (Gene)
Dexbrompheniramine may cause a minor interaction that can limit clinical effects when taken with Hyaluronidase
Dexbrompheniramine may cause a moderate interaction that could exacerbate diseases when taken with Valproic acid
Dexbrompheniramine may lead to a major life threatening interaction when taken with Potassium chloride
Dexbrompheniramine (Compound) resembles Doxylamine (Compound) and Dexbrompheniramine may cause a moderate interaction that could exacerbate diseases when taken with Doxylamine